Confirm the finding.
Then define its context.
Practical imaging and clinical decisions for sonographers, MFM physicians and APPs.
Take the 10-question quiz →Dr. Chukwuma Onyeije · OpenMFM
Reviewed September 24, 2026
OpenMFM · fetal cardiac imaging
Fetal pericardial effusion
Diagnosis, hallmarks and troubleshooting
Learning objectives · educational synthesis
Four decisions make the examination actionable
What should the next person on the care team be able to decide?
01 · Confirm
Fluid, myocardium or artifact?
02 · Characterize
Which compartment? What depth and distribution?
03 · Investigate
Is there associated fetal or maternal disease?
04 · Follow
Resolving, stable or deteriorating?
Sonographers: acquire and communicate. MFM / APPs: integrate findings, counsel and arrange the next assessment.
Synthetic case · no patient data
A dark rim is not yet a diagnosis
Teaching case: a 22-week fetus has a 2.3-mm “rim” on one saved four-chamber image.
Fetal lie is difficult. No orthogonal cine clip is available.
What needs to happen before calling this an effusion?
Reveal the next scanning step
Reacquire optimized views. Trace the complete myocardial wall, establish a separate external collection, and document fluid-only measurement. A single number cannot rescue uncertain anatomy.
Anatomic hallmark
True fluid lies outside the full myocardial wall
Identify both boundaries before placing a caliper.
Epicardium = outer myocardial surface / visceral pericardium. The fluid space separates it from the parietal pericardium.
Guideline convention + expert debate
The 2-mm convention needs anatomic context
ISUOG describes a small ≤2-mm rim at end-systole as a normal finding.
Thin expected rim
Recognize the screening convention. Do not trigger a pathologic-effusion workup for an ordinary physiologic rim.
Distinct external collection
Confirm location and reproducibility. Expert commentary challenges treating size as the sole discriminator.
Around the threshold, first resolve what is being measured. Then interpret the thickness and the rest of the examination.
Proposed acquisition workflow
Reproduce the collection before labeling it
Review a beating-heart cine and confirm the finding in another plane.
Trace the external myocardial surface.
Show a distinct space along the cardiac contour.
Review its behavior through the cycle.
A complete circumferential halo is not required. Cycle persistence supports interpretation but is not a stand-alone fetal diagnostic rule.
Caliper placement
Measure fluid only, perpendicular to its boundaries
Use end-systole when applying the ISUOG fetal screening convention.
Save the measured frame. Report depth in mm, location, view and phase. Reuse comparable technique on follow-up.
Technical troubleshooting
Change the window before declaring pathology
Optimize the image before changing the diagnosis.
Re-angle and reframe
Alter insonation or wait for a better fetal position. Use adequate magnification and appropriate focus.
Balance gain and TGC
Too little gain can erase myocardium; too much can add noise to fluid. TGC = time-gain compensation.
Preserve temporal detail
Use a narrow sector and adequate frame rate. Save cine clips rather than only still images.
Repeat and compare
Reassess the suspected space in a second plane with the full myocardial wall visible.
Suggested office QA workflow; adapt machine settings to the patient, depth and equipment.
Common fetal mimics
Myocardium and dropout can imitate fluid
A reliable interface matters more than how dark the band looks.
Hypoechoic myocardium
The band belongs to the muscle wall. Trace from the cavity outward.
Acoustic dropout
An apparent gap changes or disappears with insonation. Reacquire the boundary.
True collection
The space remains separate from the full muscle layer on adequate repeat views.
Reverberation and side-lobe clutter may add false internal echoes. Try a different window and appropriate image optimization before describing “complex” fluid.
Differential imaging
Name the compartment: heart or lung?
Pericardial fluid follows the heart; pleural fluid occupies the pleural space.
Pericardial
Pleural
Confirm with thoracic sweeps. Chest-wall edema is outside the thoracic cavity. Do not rely on a single adult descending-aorta landmark rule.
Doppler troubleshooting
Color Doppler is an adjunct, not a veto
Very low velocity settings may demonstrate movement within true fluid.
Published technique: Nyquist limits of 8–24 cm/s (0.08–0.24 m/s).
Adjust for motion artifact and color blooming; correlate with grayscale.
Historical technique study, not a universal equipment preset or validated exclusion test.
Proposed office QA workflow
Image uncertainty belongs in the report
The QA handoff should be reproducible and honest.
Save at least two adequate views and cine clips.
Store a fluid-only measurement frame with phase and location.
Document rhythm, function and the hydrops survey.
State technical limitations and diagnostic confidence.
Arrange review or repeat imaging when the finding remains uncertain.
Example: “Possible external fluid versus myocardial dropout; limited by fetal position. Repeat targeted views and physician review requested.”
Whole-fetus safety screen
Search for a second abnormal fluid compartment
Hydrops is a phenotype, not an etiology.
Pericardial effusion
Fluid around the heart.
Pleural effusion
Fluid around a lung or lungs.
Ascites
Free fluid in the abdomen.
Skin edema
Generalized abnormal skin thickening.
Two or more compartments = hydrops. An isolated pathologic effusion still deserves evaluation.
Fetal cardiology assessment
Structure, rhythm and function define the phenotype
A targeted scan does not replace a complete fetal echocardiogram.
Structure
Review chambers, outflows, arches, tumors and ventricular outpouchings.
Rhythm
Document rate and rhythm; investigate suspected tachycardia, bradycardia or conduction disease.
Function
Assess contractility, valve regurgitation and other signs of cardiovascular compromise.
Suspected abnormal cardiac screening warrants fetal echocardiography. A reassuring four-chamber still alone does not establish a normal heart.
Differential diagnosis
“Isolated” must remain true over time
A label at the first examination may change after workup or follow-up.
Fetal assessment
Detailed anatomy, growth, amniotic fluid, placenta and relevant Dopplers.
Etiologic assessment
Cardiac disease, genetic disorders, anemia, infection and other phenotype-directed causes.
No additional finding on the initial scan.
No explanation identified on the completed evaluation.
No new abnormality during subsequent surveillance.
Targeted workup
Anemia assessment requires careful Doppler technique
MCA-PSV = middle cerebral artery peak systolic velocity.
Acquire correctly
Sample near the MCA origin, with the beam as close to 0° as possible. Obtain reproducible waveforms without fetal activity.
Interpret in context
Express PSV as multiples of the gestational-age median (MoM). A reproducible value >1.5 MoM raises concern for severe anemia.
Escalate to the responsible MFM clinician and a fetal-therapy center when indicated. Doppler screens for anemia; it does not itself establish the fetal hemoglobin.
Clinical context
Review maternal red-cell antibodies and relevant exposure history. Consider parvovirus, CMV or other infection testing according to the phenotype; PCR testing is appropriate when infectious etiologies are in the differential. Fetal blood sampling/transfusion versus delivery depends on gestation and clinical status.
Current guideline · genetic counseling
Pathologic effusion merits genetic counseling
A normal screening result is not a complete diagnostic evaluation.
Offer fetal diagnostic testing: chromosomal microarray (CMA) ± karyotype.
For unexplained NIHF-spectrum disease after nondiagnostic testing, offer exome or genome sequencing.
Explain what each test can detect and its remaining limitations.
SMFM #75 (2026) applies diagnostic testing to one or more fetal effusions. Confirm pathologic fluid before entering this pathway.
Clinical context
cfDNA screens primarily for selected aneuploidies. Normal karyotype does not exclude pathogenic copy-number or single-gene disease. Do not transfer sequencing yields from heterogeneous hydrops cohorts to a small isolated pericardial effusion.
Prognosis · retrospective evidence
Confirmed isolated effusions often have favorable outcomes
The reassuring signal comes from several small observational series.
Di Salvo · 52 fetuses
Effusions 2–7 mm. No significant excess in the measured obstetric or neonatal outcomes versus hospital rates.
Kyeong · 24 isolated cases
Generally reassuring neonatal outcomes; fluid depth did not predict outcome. Genetic and follow-up ascertainment were not uniform.
Slesnick · associated findings matter
Most effusions resolved. Hydrops and extracardiac malformations identified a less favorable group.
Use the evidence to support reassurance after evaluation. These are not interchangeable cohorts of uniformly tested fetuses.
Evidence interpretation
A negative evaluation reduces risk without eliminating it
Keep the denominator attached to every estimate.
Cai · isolated genetic subgroup
1 / 16
Pathogenic finding in prenatally isolated PE (6.3%). Small, selected diagnostic-testing subgroup.
Cai · broader outcome group
71 / 79
Reported normal phenotype (89.9%) in the broader PE live-birth group, including nonisolated cases.
Neither percentage is the residual risk after a complete negative workup.
Clinical context
Cai’s three adverse outcomes after isolated, genetically normal effusions span different fluid compartments; Table 4 includes one isolated PE case. Hidalgo Sanz’s 38-fetus referral cohort reported 86.8% resolution yet later morbidity, including genetic/metabolic and developmental findings. Prenatal isolation and fluid resolution do not guarantee normal long-term outcome.
Surveillance
Follow the trajectory, not just the millimeters
Serial imaging checks whether the fetus remains well.
Track fluid using comparable technique.
Repeat hydrops, rhythm and function assessment.
Reassess growth and relevant Dopplers.
Document the next examination and escalation plan.
Clinical context
No universal isolated-PE interval is established. ASE describes 2–8-week intervals for abnormal fetal hearts depending on lesion and concern; this is not an instruction to wait that long in a worsening effusion. Individualize timing with fetal cardiology.
Specific associated finding
A ventricular outpouching is a different phenotype
A structural finding can coexist with spontaneous fluid resolution.
Zidere: four fetuses with right ventricular outpouching and large effusions improved spontaneously by the third trimester.
Serial echocardiography documented stable function and favorable postnatal outcomes.
Four cases do not establish a universal course. Do not pool these fetuses with structurally normal isolated effusions.
Escalation and fetal therapy
Deterioration changes the plan
Communicate new compromise during the examination.
Stable and isolated
Expectant care with serial imaging is usually appropriate when the evaluation is reassuring.
Increasing concern
Enlarging fluid, new hydrops, arrhythmia, impaired function or suspected lung compression warrants prompt specialist review.
Fetal pericardiocentesis is a selected fetal-center intervention. Size alone is not an automatic indication.
Clinical context
Consider the underlying cause, hemodynamic effects, gestation and alternatives. Drainage has procedural risks and fluid can recur; uncontrolled case series cannot separate procedure-related risk from disease severity.
Clinical inference + individualized planning
Birth planning follows the whole clinical picture
Make the neonatal handoff part of the prenatal plan.
Stable isolated fluid alone does not establish a need for preterm birth or cesarean.
Persistent or complex findings require a coordinated neonatal cardiac assessment.
Specify delivery location, responsible teams and the postnatal echo plan.
Delivery timing is individualized when hydrops or fetal/maternal deterioration develops. Do not apply a fixed delivery week to every effusion.
Patient-centered communication
Reassure, then explain the purpose of follow-up
Suggested counseling after a reassuring evaluation.
“The fluid is the only finding we have identified, and the heart and the rest of the evaluation are reassuring. In this setting, most babies do well and the fluid often goes away on its own.”
“We will follow the heart and your baby’s growth because new findings, although uncommon, would change the plan.”
Clinical context
Name the tests completed and what remains unresolved. “Normal karyotype” is not equivalent to excluding every genetic condition. Avoid “always benign” or a pooled percentage presented as an individual guarantee.
Proposed reporting template
Report confidence, context and the next action
Return to the 22-week teaching case: repeat images show true external fluid.
Suggested report fields
Location and distribution: ___ · Maximum depth: ___ mm
Plane and cardiac phase: ___ · Confirmatory cine/views: ___
Rhythm/function: ___ · Other fluid compartments: ___
Associated findings / growth: ___ · Technical limitations: ___
Impression, clinician notification and follow-up plan: ___
Location and distribution: ___ · Maximum depth: ___ mm
Plane and cardiac phase: ___ · Confirmatory cine/views: ___
Rhythm/function: ___ · Other fluid compartments: ___
Associated findings / growth: ___ · Technical limitations: ___
Impression, clinician notification and follow-up plan: ___
Reveal the case reasoning
Confirming fluid answers the imaging question, not the etiologic question. Complete the fetal assessment, obtain fetal echocardiography, and arrange indicated counseling/testing. If repeat views show myocardial dropout instead, document why the original measurement was not fluid.
Clinical pearls
Clinical pearls: confirm the space and follow the fetus
Seven habits make the diagnosis and handoff more reliable.
- Trace the full myocardial wall.
- Reproduce fluid in adequate views.
- Measure fluid only, in millimeters.
- Use color as an adjunct.
- Search for associated disease.
- Reassure when truly isolated.
- Escalate when the phenotype changes.
Evidence & controversies
Reassuring direction, imperfect risk estimates
Evidence & controversies: recognize what the studies can and cannot answer.
What is supported
Truly isolated effusions often resolve and generally have favorable outcomes.
What remains uncertain
Threshold interpretation, long-term residual risk and the best surveillance interval.
What research should resolve
Standardized isolation/testing definitions, prospective follow-up and intervention criteria.
Most data are small, retrospective and referral-sensitive. “Isolated at diagnosis” differs from “isolated after complete workup and follow-up.”
References · 1 of 2
References: diagnosis and evaluation
Guidelines, expert interpretation and technique studies.
- R1 · Guideline · ISUOG 2023Carvalho JS, et al. ISUOG Practice Guidelines (updated): fetal cardiac screening. Ultrasound Obstet Gynecol. 2023;61:788–803. doi:10.1002/uog.26224.Read source ↗ R1, opens in a new tab
- R2 · Expert commentary · DeVore 2024DeVore GR. Enhancement of the screening examination of the fetal heart as proposed by ISUOG Practice Guidelines. Ultrasound Obstet Gynecol. 2024;63:119–122. doi:10.1002/uog.27479.Read source ↗ R2, opens in a new tab
- R3 · Guideline · SMFM #75, 2026SMFM; Sparks TN, Norton ME; SMFM Publications Committee. Consult Series #75: Evaluation and management of non-immune hydrops fetalis. Pregnancy. 2026;2:e70208. doi:10.1002/pmf2.70208. Replaces Guideline #7.Read source ↗ R3, opens in a new tab
- R4 · Expert reference · ISUOG VISUOGMartínez JM, Masoller N. Pericardial effusion. ISUOG Visual Encyclopedia of Ultrasound in Obstetrics and Gynecology. Accessed September 24, 2026.Read source ↗ R4, opens in a new tab
- R5 · Technique study · DeVore 1994DeVore GR, Horenstein J. Color Doppler identification of a pericardial effusion in the fetus. Ultrasound Obstet Gynecol. 1994;4:115–120. doi:10.1046/j.1469-0705.1994.04020115.x.Read source ↗ R5, opens in a new tab
- R12 · Guideline · SMFM #8SMFM; Mari G, Norton ME, Stone J, et al. Clinical Guideline #8: The fetus at risk for anemia—diagnosis and management. Am J Obstet Gynecol. 2015;212:697–710. doi:10.1016/j.ajog.2015.01.059.Read source ↗ R12, opens in a new tab
- R13 · Guideline · ASE 2023Moon-Grady AJ, et al. Guidelines and Recommendations for Performance of the Fetal Echocardiogram: An Update from the American Society of Echocardiography. J Am Soc Echocardiogr. 2023;36:679–723. doi:10.1016/j.echo.2023.04.014.Read source ↗ R13, opens in a new tab
References · 2 of 2
References: outcomes and counseling
Cohort definitions and follow-up duration affect prognosis.
- R6 · Retrospective cohort · Di Salvo 1994Di Salvo DN, Brown DL, Doubilet PM, Benson CB, Frates MC. Clinical significance of isolated fetal pericardial effusion. J Ultrasound Med. 1994;13:291–293. doi:10.7863/jum.1994.13.4.291.Read source ↗ R6, opens in a new tab
- R7 · Retrospective cohort · Kyeong 2014Kyeong KS, Won HS, Lee MY, Shim JY, Lee PR, Kim A. Clinical outcomes of prenatally diagnosed cases of isolated and nonisolated pericardial effusion. Fetal Diagn Ther. 2014;36:320–325. doi:10.1159/000358591.Read source ↗ R7, opens in a new tab
- R8 · Retrospective cohort · Slesnick 2005Slesnick TC, et al. Characteristics and outcomes of fetuses with pericardial effusions. Am J Cardiol. 2005;96:599–601. doi:10.1016/j.amjcard.2005.04.027.Read source ↗ R8, opens in a new tab
- R9 · Retrospective cohort · Cai 2025Cai M, Lin N, Su L, Fu M, Huang H, Xu L. Genetic etiology and pregnancy outcomes of abnormal fluid accumulation in fetus: A retrospective cohort study. PLOS One. 2025;20:e0337437. doi:10.1371/journal.pone.0337437.Read source ↗ R9, opens in a new tab
- R10 · Case series · Zidere 2019Zidere V, Gebb J, Vigneswaran T, Charakida M, Simpson JM, Bower S. Spontaneous resolution of large pericardial effusion associated with right ventricular outpouching in four fetuses. Ultrasound Obstet Gynecol. 2019;54:701–702. doi:10.1002/uog.20194.Read source ↗ R10, opens in a new tab
- R11 · Follow-up cohort · Hidalgo Sanz 2022Hidalgo Sanz J, Fernández Ventureira V, Palanca Arias D, Pérez Pérez P, Jiménez Montañés L, AyerzaCasas A. Isolated fetal pericardial effusion follow-up: Should we worry? An Pediatr (Engl Ed). 2022;96:342–348. doi:10.1016/j.anpede.2021.02.013.Read source ↗ R11, opens in a new tab
Educational use; individualize care. All cases are fictional and all diagrams are original schematics. Evidence reviewed September 24, 2026.
Continue to the 10-question quiz →